SCHRODER INVESTMENT MANAGEMENT GROUP - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 348 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.

Quarter-by-quarter ownership
SCHRODER INVESTMENT MANAGEMENT GROUP ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q1 2021$135,000
-50.0%
7,366
-50.1%
0.00%
Q4 2020$270,000
-47.3%
14,760
-50.5%
0.00%
-100.0%
Q3 2020$512,000
+2460.0%
29,836
+2627.2%
0.00%
Q2 2020$20,000
+17.6%
1,0940.0%0.00%
Q1 2020$17,000
-22.7%
1,0940.0%0.00%
Q4 2019$22,000
-62.7%
1,094
-67.7%
0.00%
Q3 2019$59,000
-21.3%
3,389
-20.5%
0.00%
Q2 2019$75,000
-13.8%
4,2640.0%0.00%
Q1 2019$87,0004,2640.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2019
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 30,201$3,149,00019.29%
MANAGED ASSET PORTFOLIOS, LLC 1,399,878$20,046,0002.75%
Clean Yield Group 251,220$3,597,0001.27%
Mondrian Investment Partners LTD 4,319,715$60,476,0001.24%
Sippican Capital Advisors 80,490$1,153,0000.96%
TFG Asset Management GP Ltd 1,275,656$18,268,0000.83%
Lumbard & Kellner, LLC 132,516$1,898,0000.74%
BRANDES INVESTMENT PARTNERS, LP 2,109,846$30,213,0000.65%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,601,046$22,927,0000.55%
Ridgewood Investments LLC 33,378$478,0000.31%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders